FDA Status Update

globenewswire.com April 28, 2026 at 5:09 AM ET

ALVO The FDA is currently reviewing Alvotech's responses to a Form 483 following a reinspection of their facility. The outcome is pending, making the sentiment neutral.

FDA Status Update Alvotech has been informed by the U.S. Food and Drug Administration (FDA) that the responses provided to the FDA Form 483 on April 3, 2023, following the conclusion of the reinspection of the company’s Reykjavik facility on March 17, 2023, are currently under review.

Alvotech Investor Relations

Benedikt Stefansson

alvotech.ir[at]alvotech.com